Jennifer L. Eaton

ORCID: 0000-0002-6207-7412 · 4 papers in corpus
letter 2021
Round-the-clock or start-and-stop: Does the regimen matter when dydrogesterone is used to treat chronic pelvic pain due to endometriosis?
Fertility and sterility ·doi:10.1016/j.fertnstert.2021.10.018
other 2013
Increased AKT or MEK1/2 activity influences progesterone receptor levels and localization in endometriosis
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2013-1661

CONTEXT: Endometriosis is characterized by progesterone resistance and hyperactivity of the AKT and MAPK pathways. Kinases can cause posttranslational modifications of the progesterone receptor (PR) to influence cellular localization and pr…

article 2011
Effects of AKT and MEK1/2 inhibition on stromal cell viability and proliferation in endometriosis
·doi:10.1016/j.fertnstert.2011.07.177
book-chapter 2011
Overactive AKT and MAPK Pathways Promote Progesterone Receptor Degradation in Endometriosis
·doi:10.1210/endo-meetings.2011.part3.p17.p3-29